complete their maturation. YS is a source of precursor cells, however its differentiation
potential and suitability for cell therapies are not well described. YS can be a cell source
when neovascularization is required. This study characterized YS canine cells, transduced
with VEGF, to analyze then using Immunocytochemistry, flow cytometry and real time PCR.
Immunocytochemistry: positive expression for CD105, PCNA, VEGF and vWF, flow cytometry …